AAmerican Journal of Psychiatry3/18/2026Continuing Questions About Esketamine 5 Years After Approval: Response to Ahmed et al.Alan F. Schatzberg·K. N. FountoulakisRead at American Journal of PsychiatryTagsTreatment of Major DepressionPharmacology
